SCHEMBL16638757

SCHEMBL16638757

C=C/C(=C\C=C(/C)c1ccccc1F)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.42
CES1 P23141 1/20 0.42
PTPN1 P18031 1/20 0.41
ERCC5 P28715 1/20 0.41
FEN1 P39748 1/20 0.41
GAA P10253 1/20 0.40
ALDH1A1 P00352 2/20 0.40
ALOX15 P16050 1/20 0.40
NPC1 O15118 4/20 0.38
RAB9A P51151 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
KMT2A Q03164 5/20 0.37
MEN1 O00255 4/20 0.37
TSHR P16473 1/20 0.37
HTT P42858 1/20 0.36
PKM P14618 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
GPR52 Q9Y2T5 1/20 0.35
HPGD P15428 2/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22924919 0.79 AKT1 (0.47) CES2CES1ALDH1A1NPC1RAB9A
SCHEMBL17266589 0.77 CES2 (0.43) CES2CES1PTPN1ERCC5FEN1
SCHEMBL16502018 0.76 CES2 (0.41) CES2CES1PTPN1ERCC5FEN1
SCHEMBL24230171 0.73 HCAR2 (0.34) PTPN1ERCC5FEN1NPC1RAB9A
SCHEMBL15705122 0.73 CES2 (0.48) CES2CES1PTPN1ERCC5FEN1
SCHEMBL18554814 0.72 ALDH1A1 (0.53) CES2CES1PTPN1ERCC5FEN1
SCHEMBL149580 0.72 ALDH1A1 (0.53) CES2CES1PTPN1ERCC5FEN1
Propene SCHEMBL28028230 0.70 CES2 (0.54) CES2CES1PTPN1ERCC5FEN1
SCHEMBL30634467 0.69 CES2 (0.58) CES2CES1PTPN1ERCC5FEN1
SCHEMBL118109 0.69 CES2 (0.58) CES2CES1PTPN1ERCC5FEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161273-B1 Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment LEUVEN K U RES & DEV (BE) 2015-04-15 EP disclosed